ストックスクリーナーアプリを入手
32.84
2.49%
-0.84
プレマーケット:
33.10
0.26
+0.79%
前日終値:
$33.68
開ける：
$32.0617
24時間の取引高:
9.87M
Relative Volume:
0.42
時価総額：
$7.60B
収益：
$2.35B
当期純損益:
$128.37M
株価収益率:
62.90
EPS:
0.5221
ネットキャッシュフロー:
$57.42M
1週間 パフォーマンス:
-4.48%
1か月 パフォーマンス:
+2.98%
6か月 パフォーマンス:
+4.65%
1年 パフォーマンス:
-34.31%
1日の値動き範囲:
$31.91
$34.04
1週間の範囲:
$31.91
$37.70
52週間の値動き範囲:
$13.74
$70.43
Hims Hers Health Inc Stock (HIMS) Company Profile
Compare HIMS vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
32.84 | 7.80B | 2.35B | 128.37M | 57.42M | 0.5221 |
TAK
Takeda Pharmaceutical Co Adr
|
17.15 | 53.43B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.10 | 44.52B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.03 | 37.52B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.56 | 32.24B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
535.67 | 22.46B | 3.17B | 1.29B | 1.01B | 27.09 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-24 | 開始されました | JP Morgan | Overweight |
| 2026-03-10 | アップグレード | BofA Securities | Underperform → Neutral |
| 2026-03-10 | アップグレード | Citigroup | Sell → Neutral |
| 2026-03-09 | アップグレード | Needham | Hold → Buy |
| 2026-02-24 | ダウングレード | BTIG Research | Buy → Neutral |
| 2026-01-12 | 開始されました | Evercore ISI | In-line |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | ダウングレード | Needham | Buy → Hold |
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
Technical Reactions to HIMS Trends in Macro Strategies - Stock Traders Daily
HIMS Announces Departure of Chief Accounting Officer Irene Beckl - GuruFocus
Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company - 01net
Hims & Hers Health Announces Accounting Officer Resignation - TipRanks
HIMS: Leadership Change as Chief Accounting Officer Steps Down - GuruFocus
Hims & Hers Health: CFO Yemi Okupe Will Assume Responsibilities of CAO During Search for Permanent CAO >HIMS - Moomoo
Hims & Hers chief accounting officer to depart in October - Investing.com
Hims & Hers chief accounting officer to depart in October By Investing.com - Investing.com Canada
Hims & Hers Health (NYSE: HIMS) plans CAO Becklund exit - Stock Titan
3 Reasons HIMS Has Explosive Upside Potential - Yahoo Finance
Why Hims & Hers Health (HIMS) Stock Is Down Today - Quiver Quantitative
Why Is Hims & Hers Health (NYSE:HIMS) Scaling Virtual Care Services? - Kalkine Media
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Hims & Hers Health Inc (CHIX:82Wd) Stock Price, Trades & News - GuruFocus
Hims & Hers Health (NYSE:HIMS): What Is Driving Attention? - Kalkine Media
This Trade Offers Two Ways To Profit From Hims & Hers Stock - Investor's Business Daily
2026-07-16 | Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:HIMS | Press Release - Stockhouse
Breakout attempt at $39.02 resistance. Can Hims & Hers Health stock extend gains? - Traders Union
A Look at Hims & Hers Health Inc (HIMS) After 5.8% Gain -- GF Va - GuruFocus
Law firm investigates Hims & Hers for allegedly sharing users' private health data without consent. - Pluang
Lowey Dannenberg, P.C. Investigates Hims & Hers Health, Inc. for Alleged Tracking of User Data - GlobeNewswire
Lowey Dannenberg, P.C. Investigates Hims & Hers Health, Inc. for Alleged Tracking of User Data - GlobeNewswire Inc.
Why is Hims & Hers Health stock up 6.1% today? - Traders Union
Hims & Hers Health shares gain more than 5% after price action confirms trend alignment above key moving averages - Traders Union
Why is Hims & Hers Health stock up today? Resistance test in focus for HIMS - Traders Union
Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Hims & Hers to announce Q2 2026 results on August 10 - scanx.trade
Is most-watched stock Hims & Hers Health, Inc. (HIMS) worth betting on now? - MSN
Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026 - HIMS Investor Relations
HIMS Stock Logs Worst Week In 2 Months — Turns To Peptides Campaign Ahead Of Key FDA Meeting - Stocktwits
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? - Yahoo Finance
Why Is HIMS Stock Slipping Premarket Today? - Stocktwits
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims - AOL.com
A Look at Hims & Hers Health Inc (HIMS) After 3.0% Decline -- GF Value $39.29 vs Price $34.38 - GuruFocus
Why Hims & Hers Health Shares Are Falling Today - Quiver Quantitative
Hims & Hers Health Stock (HIMS) Opinions on Recent Technical Breakouts and Growth Prospects - Quiver Quantitative
HIMS Stock Rises Overnight: CEO Shrugs Off Wild Swings, Bets On ‘Gold Standard’ Of Healthcare Over Next Decade - Stocktwits
HIMS Stock Under Pressure: BofA Warns Wegovy Churn Could Threaten Its Big H2 EBITDA Ramp - Stocktwits
HIMS Stock Hits 2026 High After Unlocking $400M Working Capital Through JPMorgan — Retail Gets Less Bearish - Stocktwits
Hims & Hers Health (HIMS) Draws GLP 1 Attention, Is The Valuation Already Too Rich? - simplywall.st
$Hims & Hers Health (HIMS.US)$ Why Wall Street is watching $HIMS beyond this quarter’s earnings - Moomoo
Truist reiterates Hold on Hims and Hers stock, $23 target on peptide uncertainty - Investing.com
Hims & Hers (HIMS) Stock Jumps 45% — Can This Momentum Continue? - Blockonomi
HIMS Maintains by B of A Securities -- Price Target Raised to $3 - GuruFocus
$Hims & Hers Health (HIMS.US)$ ⸻ $HIMS remains one of the m... - Moomoo
BofA raises Hims and Hers stock price target to $37 on growth - Investing.com Canada
Hims & Hers Health (Ondo Tokenized Stock) Price - Decrypt
Short Seller Who Bet Against Hims & Hers Now Says Its CEO 'Wiped The Floor' With Novo Nordisk - Stocktwits
Hims & Hers Health Options Spot-On: On July 8th, 71,332 Contracts Were Traded, With 958.81K Open Interest - Moomoo
Hims & Hers Health: The Market Still Doesn't Get It - Seeking Alpha
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
Hims Hers Health Inc (HIMS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Okupe Oluyemi | Chief Financial Officer |
Jul 06 '26 |
Sale |
36.49 |
7,163 |
261,351 |
284,321 |
1.50%
0.79%
大文字化:
|
ボリューム (24 時間):